Rivaroxaban, Another New Oral Anticoagulant Approved
On July 1, the FDA approved rivaroxaban (Xarelto), an oral once daily anticoagulant for prevention of deep vein thrombosis in patients undergoing knee or hip replacement surgery. This is the second new oral anticoagulant approved within the past year, after over 50 years with warfarin (Coumadin) as the only choice. The drug is approved for … Read more…